<DOC>
	<DOCNO>NCT02451592</DOCNO>
	<brief_summary>The purpose study determine risk factor fungemia population patient diagnose hematologic malignancy eligible chemotherapy .</brief_summary>
	<brief_title>Fungemia Hematologic Malignancies</brief_title>
	<detailed_description>The coordinating center provide participate center epidemiologic form , order collect data comparable way . The requested information include type malignancy treatment , environmental exposition , laboratory work , antifungal prophylaxis , clinical sign infection , microbiological finding , antifungal therapy outcome infection 30 day . The planned sample size 300 patient recruit 35 participate center 5 year , retrospective-prospective fashion . Data check perform coordinate center . Missing data manage minimize incomplete report . Statistical analysis perform independent reviewer , order ass risk factor predictive fungal infection outcome .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Fungemia</mesh_term>
	<criteria>Patients diagnose hematologic malignancy eligible chemotherapy Patients eligible chemotherapy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Fungemia</keyword>
	<keyword>Hematologic malignancy</keyword>
</DOC>